Vijay Mishra

Employment

• Lovely Professional University Professor
  2021 - Present
• Lovely Professional University Associate Professor
  2016 - 2021

Education

• Dr. H. S. Gour Central University PhD (Pharmaceutics)
  2011 - 2015
• Dr. H. S. Gour Central University M.Pharm (Pharmaceutics)
  2005 - 2007
• Dr. H. S. Gour Central University B.Pharm
  2001 - 2005

Projects & Funding

Projects & funding information is unavailable.

Publications (124)

• The Synergistic Role of Phenolic Compounds in Docetaxel Chemoresistance in Prostate Cancer: A Systematic Review and Meta-Analysis
  Current Pharmaceutical Design 2026 DOI: 10.2174/0113816128479433260709091532
  +Save
• RETRACTED: Bakshi et al. Crocin Inhibits Angiogenesis and Metastasis in Colon Cancer via TNF-α/NF-kB/VEGF Pathways. Cells 2022, 11, 1502
  Cells 2026 DOI: 10.3390/cells15131197
  +Save
• Curcumin-based Nanotherapeutics to Combat Neurodegenerative Disease: Drug Delivery Strategies and Therapeutic Potential
  Current Drug Delivery 2026 DOI: 10.2174/0115672018480691260520045205
  +Save
• Diversity of Moths in The Sacred Grove of Mehal Nag Temple and Rugged Terrain of Chamba District, Himachal Pradesh
  Indian Journal of Entomology 2026 DOI: 10.55446/IJE.2026.3611
  +Save
• QBD ENABLED DEVELOPMENT AND VALIDATION OF A GREEN REVERSE-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR SIMULTANEOUS QUANTIFICATION OF SELEGILINE AND BRAHMI (BACOPA MONNIERI) EXTRACT
  International Journal of Applied Pharmaceutics 2026 DOI: 10.22159/ijap.2026v18i4.58355
  +Save
• Functionalized Carbon Nanotubes: An Advanced Tool with Enhanced Biomedical Attributes
  Current Nanomedicine 2026 DOI: 10.2174/0124681873331266241003104137
  +Save
• Smart wearable biosensors: a transformative synergy between diagnosis and treatment of disease
  RSC Advances 2026 DOI: 10.1039/D6RA02749K
  +Save
• Natural killer cell therapies in cancer: innovations, challenges, and future directions
  Expert Opinion on Biological Therapy 2025 DOI: 10.1080/14712598.2025.2601053
  +Save
• DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR THE DETERMINATION OF RESVERATROL IN BULK DOSAGE FORM, COMMERCIAL TABLET, AND MULTIWALLED CARBON NANOTUBES-BASED FORMULATION
  International Journal of Applied Pharmaceutics 2025 DOI: 10.22159/ijap.2025v17i6.54953
  +Save
• Cathepsin C: a critical mediator between immune response and cardiovascular disease – therapeutic implications of enzyme inhibition
  Drug Development and Industrial Pharmacy 2025 DOI: 10.1080/03639045.2025.2571722
  +Save